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Abstract: Advancement and innovation in bone regeneration, specifically polymeric composite
scaffolds, are of high significance for the treatment of bone defects. Xyloglucan (XG) is a
polysaccharide biopolymer having a wide variety of regenerative tissue therapeutic applications
due to its biocompatibility, in-vitro degradation and cytocompatibility. Current research is focused
on the fabrication of polymeric bioactive scaffolds by freeze drying method for nanocomposite
materials. The nanocomposite materials have been synthesized from free radical polymerization
using n-SiO2 and n-HAp XG and Methacrylic acid (MAAc). Functional group analysis, crystallinity
and surface morphology were investigated by Fourier transform infrared spectroscopy (FTIR),
X-ray diffraction analysis (XRD) and scanning electron microscopy (SEM) techniques, respectively.
These bioactive polymeric scaffolds presented interconnected and well-organized porous morphology,
controlled precisely by substantial ratios of n-SiO2. The swelling analysis was also performed in
different media at varying temperatures (27, 37 and 47 ◦C) and the mechanical behavior of the
dried scaffolds is also investigated. Antibacterial activities of these scaffolds were conducted against
pathogenic gram-positive and gram-negative bacteria. Besides, the biological behavior of these
scaffolds was evaluated by the Neutral Red dye assay against the MC3T3-E1 cell line. The scaffolds
showed interesting properties for bone tissue engineering, including porosity with substantial
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mechanical strength, biodegradability, biocompatibility and cytocompatibility behavior. The reported
polymeric bioactive scaffolds can be aspirant biomaterials for bone tissue engineering to regenerate
defecated bone.
Keywords: antibacterial active; biocompatibility; nanotechnology; nanocomposite scaffolds; bone
tissue engineering
1. Introduction
Bone tissue damage caused by trauma, injury or disease needs progressive approaches for tissue
repair and development. Bone tissue engineering is an innovative technique for the treatment of
defected and broken bones using composite scaffolds. Bone is a vital part of the body, supporting
and protecting the soft tissues and help to maintain the structure. In recent years, scientists have
contributed a great deal of effort for bone tissue engineering and regenerative medicine to resolve
bone augmentation complications [1,2]. Numbers of bone grafting have increased significantly in
the last few decades due to the increasing number of bone damage in accidents or other traumas.
Biomaterial-based bone regeneration is an effective alternative because of the materials’ intrinsic
properties. The bioactive composite scaffolds are implanted to treat defected or fractured bone sites
and integrated into the osteochondral system [3,4]. The limitations of auto-grafts because of donor
availability issues compelled scientists to develop biocompatible composite materials for bone tissue
engineering. We are reporting here polymeric scaffolds, synthesized for the bone tissue applications,
because of their anticipated porous, physicochemical, degradability and biomechanical properties
with tunable characteristics [5,6]. Typically, tissue-engineering approaches involve porous composite
scaffolds for living cells. The ceramic material offers sufficiently porous, rough morphology and
polymer imitation of the extracellular matrix. Due to biocompatible, biodegradable and bioactive
activities, the polysaccharides have drawn the attention of researchers in tissue engineering. Because
of its physical and chemical, it proved to be a potential candidate for wound dressing and tissue
engineering because of non-allergic or non-inflammatory response [7,8].
Xyloglucan (XG) is also a well-known biological macromolecule with wide biomedical applications.
It is famous for pharmaceutical applications due to controlled swelling ability, biocompatibility and
biodegradable properties with water-soluble and non-toxic and nonirritant polysaccharide. XG consists
of polysaccharide 1,4-β-D-glucan backbone with partial substitutions of the 1,6-β-D-xylopyranosyl
side chain and additionally substituted with 1,2-β-D-galactopyranosyl residue [9,10]. The commercial
tamarind kernel powder is a significant source of XG raw material. XG has bared many applications;
it has been used as a common excipient in cosmetics, food additive and acts as stabilizer and thickener
agents [11,12]. A suitable polymeric composite was prepared via blending with cations Ca2+ and
these cations interacted with a negatively charged hydroxyl group (OH−) of polysaccharide chain
due to the electrostatic force of interaction, which resulted in the formation of the 3D network.
Polysaccharide-based scaffolds have a limitation because of poor/inadequate mechanical properties.
Ceramic-based materials (hydroxyapatite (HAp)) have substantial mechanical and biocompatibility
for hard tissue engineering [13]. In the present study, silica has been selected as an essential
material, well known for its lightweight and excellent mechanical properties. Biomaterials based
on nanocomposites gained the attention of scientists because of their porous, wide surface area
and biocompatibility, compared to other ceramic materials [14,15]. Silicon dioxide or silica (SiO2)
demonstrates numerous applications in drug delivery and tissue engineering as an ultimate biomaterial.
SiO2 nanoparticles have a wide surface area, resembling the biopolymer matrix of bio-composite
materials. Bioglass with silica nanoparticles not only provides mineralizing, porous and lightweight
capabilities for polymeric scaffolds but also increases its strength as a polymer composite scaffold,
having desirable biomaterial properties [16,17].
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Nisbet et al. has used XG and functionalized it by positive charge molecules of poly(D-lysine),
which showed an appropriate atmosphere for cell culture, migration and proliferation. Moreover,
the thermo-responsive hydrogels have shown returns of spinal cord injuries treatments [18]. Shaw et al.
prepared carboxymethyl tamarind gum-based films for skin tissue engineering by the phase-separation
method. They found that enhanced proliferation of human keratinocytes than the control group. It was
found that drug-loaded films showed good antimicrobial behavior against Escherichia coli and results
showed that films are suitable as matrices for skin tissue engineering [19]. Yoganand and coworkers
have synthesized glass-ceramics from natural bovine HAp/SiO2–CaO–MgO glass composites by the
brisk process. They have performed biological studies on cultures of human fibroblast cells and found
promoted adherence and growth [20]. K. Mediaswanti et al. have deposited SiO2/HAp onto a titanium
and tantalum surface by electron beam evaporation and magnetron sputtering. They found that
HAp/SiO2 coated surface was less desirable results of bacteria adherence than non-coated surface [21].
Hence, considering the physicochemical and biomechanical behavior of biomaterials, the objectives
of this article are to prepare, characterize and biological analysis of polymeric bioactive scaffolds (PBSs).
Nanoparticles of SiO2 (n-SiO2, auxiliary component) and nanoparticles of HAp (n-HAp, supplementary
constituent) lodged into a grafted biopolymeric network during free-radical polymerization of XG
with methacrylic acid (MAAc). According to our best knowledge, the methodology of polymeric
bioactive scaffolds has never reported up till now. n-SiO2 doped polymeric bioactive scaffolds have a
porous, large surface and biocompatible properties for osteogenesis. The structure and morphology of
polymeric bioactive scaffolds were analyzed by Fourier transform infrared spectroscopy (FTIR), X-ray
diffraction analysis (XRD), energy-dispersive X-ray spectroscopy (EDS), scanning electron microscopy
(SEM) and Brunauer–Emmett–Teller (BET). The mechanical behavior and swelling properties were
analyzed using the universal testing machine (UTM) in water and phosphate buffer saline (PBS) solution,
respectively. MC3T3-E1 cell line was employed to study the biological behavior of polymeric bioactive
scaffolds in vitro. The results of our study revealed, bioactive scaffolds as potential biomaterials to
regenerate and repair defective bone in tissue engineering. Figure 1 illustrates the schematic diagram
of the reported studies.
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Figure 1. The schematic diagram describes the fabrication, characterizations, an in vitro study of
polymeric bioactive scaffolds using nanoparticles of ceramic doped in a grafted biopolymeric matrix
of xyloglucan.
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2. Materials and Methods
2.1. Materials
XG was purchased from DSP Gokyo Food and Chemical Co. Ltd., Tokyo, Japan. MAAc and
N,N’-methylene-bis-acrylamide (N, N-MBA) as a crosslinker, n-HAp (<100 nm particle size) and n-SiO2
(10–20 nm particle size) in powder forms were purchased from Sigma-Aldrich, Selangor, Malaysia.
Analytical graded Na2HPO4, NaCl, KCl, K2HPO4 and HCl were obtained from Merck Darmstadt,
Germany for the preparation of buffer saline solution. All chemicals were used without any purification.
2.2. Polymeric Bioactive Scaffolds Synthesis
Synthesis of nanocomposite to fabricate polymeric bioactive scaffolds, 2 g XG in deionized-water
and shifted in round bottom two-neck flask. The reaction media temperature was held at 60 ◦C
with constant stirring under N2 atmosphere and 0,05 g potassium persulfate was used as an initiator.
After 20 min, 0.40 mL MAAc and N, N-MBA (0.05% of MAAc) were poured into the reaction media.
After 45 min, different quantities of n-SiO2 (0.25, 0.50, 0.75 and 1.0 g) and coded as PBS1, PBS2, PBS3 and
PBS4, respectively. Then, n-Hap (2 g) powders were added gradually with continuous stirring for 3 h.
Hence, MAAc was grafted into XG using a free-radical polymerization method. As a result, n-SiO2 and
n-HAp were incorporated into the XG-graft-MAAc polymeric network. On completion, the reaction
was halted and the gas flow was removed to cool the reaction media. The residual suspension was
separated by vacuum filtration from the reactive mixture. The residues were washed with excessive
deionized water, then dried overnight in the oven at 55 ◦C to obtain the nanocomposite powder.
Then the composite powder was prepared with different compositions of n-SiO2, as summarized in
Table 1. The polymeric nanocomposite powder (0.5 g) was homogeneously mixed in deionized water
to form a uniform paste, filled in cylindrical molds (1.5 mm × 6 mm) and kept at −80 ◦C for 24 h.
The cylindrical polymeric bioactive scaffolds were obtained through the freeze-drying method with
no significant volume reduction or deformation. The porous morphology of the polymeric bioactive
scaffolds was observed through Brunauer–Emmett–Teller (Micromeritics Gemini II 2370, Micromeritics,
Norcross, GA, USA).
Table 1. Percentage of porosity, pore size and n-SiO2 amount.
Samples n-SiO2 (g) Pore Size (µm) Porosity (%) Compression Strength (MPa)
PBS1 0.25 97 ± 2.43 65.5 ± 1.31 2.49 ± 1
PBS2 0.50 107 ± 3.42 75.2 ± 3.41 3.34 ± 2
PBS3 0.75 132 ± 5.06 84.5 ± 6.21 5.61 ± 1
PBS4 1.00 173 ± 8.12 91.5 ± 4.19 6.94 ± 1
3. Characterization
3.1. Fourier Transform Infrared Spectroscopy
Functional groups of the polymeric bioactive scaffolds were investigated through IR Prestige-21,
Shimadzu (Kyoto, Japan) with a frequency range of 4000−400 cm−1 and resolution of 4.0 cm−1 with
200 scans average per spectrum.
3.2. Scanning Electron Microscope/Energy Dispersive Spectroscopy
Morphologies of the polymeric bioactive scaffolds have been analyzed by scanning electron
microscope (SEM, JEOL-JSM-6480, Akishima, Japan) coupled with energy dispersive spectroscopy
(EDS) for elemental quantitative analysis. Cross-sectional pieces of the scaffolds were sliced and placed
on a stub and located into the vacuum chamber to collect images at different magnifications.
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3.3. Mechanical Testing
A universal testing machine (UTM), (Testometrics, UK) was employed for mechanical testing
with a loading rate of 5 mm/min. Ultimate compression strength (UCS) of the samples was determined
using triplicate.
3.4. Swelling Test
Dried specimens of scaffolds were weighted (WD) at pH 7.4 and 27, 37 and 47 ◦C, swelling behavior
of dried specimens of scaffolds was conducted in deionized H2O and PBS solution. PBS solution was
prepared in the laboratory by standard method. The pH of the solution was maintained at 7.4 by
adding hydrochloric acid (0.1 mol L−1) dropwise and raised the volume of PBS solution to 1 L by
adding deionized water. Then, scaffolds specimens were soaked and liquid-immersed into pores until
equilibrium reached. The swelled specimens of scaffolds took out from liquid and removed the excess
surface water to determine their weights (WS). The swelling (%) of the scaffolds was evaluated using
Equation (1).
Swelling (%) =
WS −WD
WD
× 100 (1)
Whereas, WS = scaffold weight, WD = Weight of dry scaffold
3.5. In Vitro Studies
In vitro studies were conducted from the extracts of polymeric bioactive scaffolds to investigate
antibacterial activities and biological activities against various bacterium (E. coli, S. aureus and
P. Aeruginosa) and mouse pre-osteoblast (MC3T3-E1) cell lines.
3.5.1. Antibacterial Activities
The antibacterial activities of all samples were studied by the disc diffusion method against
gram-negative and gram-positive model bacterial strains (E. coli, S. aureus and P. Aeruginosa).
These bacterial strains were incubated at 37 ◦C to study antibacterial activities of all polymeric
bioactive scaffolds. Hot molten (15 mL) of agar was poured into three sterile Petri-plates and left them
for solidification. After that, these bacterial cultures were spread uniformly using sterile cotton swab
over solidified agar [22]. 85 µL of each scaffold extract was put over bacterial cultured plates and
incubated into the oven for 24 h at 37 ◦C.
3.5.2. Extract of Scaffold Preparation
All polymeric bioactive scaffolds exhibited characteristics like porosity, swelling and mechanical
properties. Five different concentrations (0.125–2.00 mg mL−1) were prepared from all samples of
polymeric bioactive scaffolds in liquid to evaluate cell viability. The bottoms of 24 well plates were fine
coated for all samples in triplicate and sterilized under UV-light for 1 h.
3.5.3. Cell Culture and Morphological Analysis
Mouse pre-osteoblast (MC3T3-E1) cell line obtained from ATCC (American Type Culture Collection)
was kept in α-MEM (without ascorbic acid Gibco™ A10490-9, New York, NY, USA) with 10% FBS
(Fetal Bovine Serum Gibco™ 12662011, New York, NY, USA) and 100 U/mL Penicillin/Streptomycin
solution (Gibco™ 15140122, New York, NY, USA). To conduct microscopy-based morphological
analysis, all wells of 24 well plates were seeded with approximately 5000 cells per cm2 for five different
concentrations using the same media in triplicate and incubated at 37 ◦C for 72 h in 5% CO2 with 90%
humidity. The Nikon Eclipse TS100 inverted microscope (Nikon Instruments Inc, New York, NY, USA)
was employed to observe cell morphology and cell viability assay for 72 h changes.
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3.5.4. Cell Cultural and Morphological Studies
Cell culture images of the polymeric bioactive scaffold were captured using SEM (JSM 6940A, Jeol,
Tokyo, Japan). At room temperature, the attached cells were washed with PBS solution using absolute
ethanol for 7 min. Then, samples were gold-sputtered and analyzed under 1 kV voltage, 7 × 10−2 bar
pressure and 20 mA deposition current for 2.0 min.
3.5.5. Cell Culture Viability
Mouse pre-osteoblast (MC3T3-E1) cell line obtained from ATCC was kept in α-MEM (without
ascorbic acid Gibco™ A10490-9, New York, NY, USA) with 10% FBS (Fetal Bovine Serum Gibco™
12662011, New York, NY, USA) and 100 U/mL Penicillin/Streptomycin solution (Gibco™ 15140122,
New York, NY, USA). Microscopic based cell morphology was observed. Approximately 5,000 cells per
cm2 were seeded into wells of 12 well plates with five different concentrations of PBS3 and incubated at
37 ◦C for 72 h in 5% CO2 with 95% humidity. Gelatin coating is frequently used to enhance surface cell
adherence. Herein, gelatin with a concentration of 0.1% was used as a positive control. The cells were
seeded with five different concentrations (0.125–2.00 mg mL−1) with 1% dimethyl sulfoxide (DMSO) as
a negative control and non-treated cells as a positive control. Cells were incubated for 24, 48, 72 h and
the Neutral Red uptake assay was performed reported by Repetto et al. [23]. Every day, three wells
for each concentration and three for negative control were taken out. The treated and control cells
were incubated in neutral red medium (40 µgmL−1 Neutral Red medium) for 2 h. Then, the incubated
cells were washed with an excessive amount of PBS solution to remove the Neutral Red medium and
all samples were then transferred to a de-staining solution (1% glacial acetic acid 49% distilled water
and 50% ethanol) for 5 min at room temperature. The spectrophotometer was used to measure optical
density at 540 nm and cell viability (%) was determined by Equation (2).
Cell viability (%) =
ODS
ODC
× 100 (2)
where ODS and ODC for sample concentration and ODC are OD for positive control having
untreated cells.
3.5.6. Statistical Analysis
Experimental data was conducted in triplicate form and presented with mean standard errors
(S.E). The statistical analysis was calculated using statistical analysis system software (IBM, SPSS
Statistics 21). The means and standard errors of means (mean ± S.E) were calculated for every analysis
and S.E values have displayed as Y-error bars in Figures. The error bars displayed standard deviations
(p < 0.05 (5 %); size of the sample n = 3).
4. Results and Discussion
Polymeric bioactive scaffolds were produced using the freeze-drying method. The doped n-HAp
and n-SiO2 were accompanied through a free-radical polymerization process in a grafted polymer
matrix of XG and MAAc. Figure 2 indicates the relationships between the materials and possible
chemical reactions.
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Figure 2. Proposed chemical reaction scheme of polymeric bioactive scaffolds fabrication of n-HAp
and n-SiO2 doped in a grafted biopolymeric matrix of XG.
4.1. FT-IR
Figure 2 shows the proposed chemical interactions among XG, MAAc, N, N-MBA, n-HAp and
n-SiO2. Stretching vibrations at 1220 c −1,1033 cm−1 and a weak peak at 906 cm−1 are due to C–O
cyclic, acyclic and pyranose, respe tively and it might b du to formation of the c valent bond
between XG and MAAc as shown in Figure 2 [24]. FTIR spectra represent specific functional groups in
polymeric bioactive scaffolds. Bands from 3600 to 3100 cm−1 (Figure 3) are due to hydroxyl stretching
vibra ion . The band ab o ption at 2950–2850 cm−1 shows the aliphatic C–H stretching vibration.
peak featu es at 1093 cm−1 are due to triply degenerated P–O str tc i g components, while
peaks at 603 and 569 cm−1 are attributed to O–P–O bending mode. Hence, FTIR spectra present the
characteristic bands in regions 560–600 cm−1 and 1000–1100 cm−1 are assigned to calcium phosphate
moiety of n-HAp [25]. Furthermore, the absorption band at 630 cm−1 confirms the res nce of n-HAp
in all the fabricated polym ric bioactive scaffolds [26,27]. The 947 cm−1 band defines the formation
of Si–O hydrogen-bonding with XG hydroxyl groups. Rising peak inte sity from 947 to 921 cm−1
was bserved as n-SiO2 increase . The H-bond formation betwe the oxygen atom of n-SiO2 and
hydrogen toms of the hydroxyl group of XG is p esented in Figure 3. The characteristic peak is shown
b n-SiO2 from 600 to 800 cm−1 presenting the stretching vibration of Si–O–Si for polymeric bioactive
caffolds [28]. Analysis of the FT-IR spectral profile confi ms the successful synthesis of nanoc mposite
for the development of bioactive scaffolds.
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bioactive scaffolds.
4.2. Mechanical Testing
Figure 4 illustrates the compression strength of bioactive scaffolds samples in our study. It is
highly challenging but important to maintain the mechanical strength of our scaffolds during cell
growth and proliferation. It not only physically safeguards the cells but also provides compatible
mechanical strength to mimic in vivo environments that have stronger influences over cell proliferation
and differentiation. The ceramic phase (n-HAp and n-SiO2) has an extraordinary role to increase
biomechanical features of several polymeric materials [29,30]. The incorporation of n-SiO2 increased
the compression strength of the polymeric bioactive scaffolds (UCS of PBS1 = 2.4 MPa, PBS2 = 3.2 MPa,
PBS3 = 5.7 MPa, PBS4 = 6.9 MPa). The sample PBS3 has better efficacy to bear the load with suitable
porosity levels that eventually increased the mechanical properties of the fabricated polymeric bioactive
scaffold. All polymers have different chemical structures that affect the grain boundary of the matrix.
The properties of ceramic material (n-HAp and n-SiO2) is a function of pore size, porosity and grain
boundary that is decreased with decreasing in grain size.
Polymers 2019, 11, x FOR PEER REVIEW 8 of 17 
 
 
Figure 3. Typical spectral Fourier transform infrared spectroscopy (FTIR) profiles present peaks for 
different functional groups and their various modes of vibrations for all samples of polymeric 
bioactive scaffolds. 
4.2. echanical Testing 
Figure 4 illustrates the co pression strength of bioactive scaffolds sa ples in our study. It is 
highly challenging but i portant to aintain the echanical strength of our scaffolds during cell 
growth and proliferation. It not only physically safeguards the cells but also provides compatible 
mechanical strength to mimic in vivo environments that have stronger influences over cell 
proliferation and differentiation. The ceramic phase (n-HAp and n-SiO2) has an extraordinary role to 
increase biomechanical features of several polymeric materials [29,30]. The incorporation of n-SiO2 
increased the compression strength of the polymeric bioactive scaffolds (UCS of PBS1 = 2.4 MPa, PBS2 
= 3.2 MPa, PBS3 = 5.7 MPa, PBS4 = 6.9 MPa). The sample PBS3 has better efficacy to bear the load with 
suitable porosity levels that eventually increased the mechanical properties of the fabricated 
polymeric bioactive scaffold. All polymers have different chemical structures that affect the grain 
boundary of the matrix. The properties of ceramic material (n-HAp and n-SiO2) is a function of pore 
size, porosity and grain boundary that is decreased with decreasing in grain size. 
 
Figure 4. Different mechanical behavior of polymeric bioactive scaffolds. (A) Strain-stress curve of 
polymeric bioactive scaffolds and (B) Ultimate compression strength data curves of polymeric 
bioactive scaffolds. 
Figure 4. Different mechanical behavior of polymeric bioactive scaffolds. (A) Strain-stress curve
of polymeric bioactive scaffolds and (B) Ultimate compression strength data curves of polymeric
bioactive scaffolds.
Polymers 2020, 12, 1238 9 of 16
4.3. Swelling Analysis
Figure 5 discusses the swelling analysis of polymeric bioactive scaffolds in deionized-water and
phosphorous buffer saline solution. Identical amounts of scaffolds were immersed in deionized water
and PBS solution. The polymer bioactive scaffolds are found to have diverse swelling patterns in
different media at different temperatures, because of different n-SiO2 concentrations. Osmotic pressure
may increase or decrease because of the hydrogen bonding (H- bonding) among the scaffold and media
at varying temperatures. The swelling rate decreased and osmotic forces are balanced at equilibrium
after increasing the time. The extraordinary difference in water absorption is not observed with time
until it has reached a plateau [31]. Initially, more water molecules interacted with porous scaffolds and
decreased when the equilibrium point is near. Sample (PBS1) with the maximum amount of n-SiO2
has maximum swelling in water media at 47 ◦C. Whereas, sample (PBS4) with a little amount of silica
at 27 ◦C has the least swelling. It is obvious (Figure 5) that swelling has an inverse relationship to the
ceramic quantity within the polymeric network. Due to the relatively hydrophobic nature of ceramic
materials in XG-graft-MAAc and ceramic materials, the different swelling behaviors of these bioactive
scaffolds can react as a crosslinker. As a consequence, by increasing ceramic quantities into a polymeric
network, which generates additional crosslink points in polymer networking and decreases elasticity
which decreases swelling behavior.Polymers 2019, 11, x FOR PEER REVIEW 10 of 17 
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4.4. SEM-EDX
The surface morphology of the bioactive polymeric scaffolds was examined using SEM as
shown in Figure 6. The various magnifications exhibit rough and porous topography of polymeric
bioactive scaffolds (evident from the XRD results), which remarkably encourage cell adhesion and
proliferation on the scaffold [32,33]. At higher magnification, however, the SEM images show a specific
porous morphology which also supports cell infiltration, adhesion and extracellular matrix secretion.
The bioactive polymeric scaffolds show different pore sizes distributed uniformly through the samples.
The average pore size of PBS3 is 80–140 µm, which is ideal for osteointegration and 50–200 µm is optimal
for cell attachment, proliferation and osteoblast cells. The PBS3 sample has a uniform distribution
of pore size in the structure and is ideal for significant cell proliferation demonstrating excellent cell
growth capability. [34]. During the SEM analysis, n-SiO2 was found to have imparted its role in porosity,
as the increasing quantity of n-SiO2 caused increased pores and porosity. The PBS3 sample was chosen
because of the uniform pore size used for chemical composition analysis with EDX [33]. EDX study
reveals the different amounts of elements present in sample PBS3. Results show the presence in
the porous bioactive scaffold of carbon (C), oxygen (O), silica (Si), calcium (Ca) and phosphorus (P)
elements (Figure 6), which help grafted-XG in manufactured bioactive polymer scaffolds.
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4.5. In-Vitro Study
The polymeric bioactive scaffolds samples were selected for in-vitro analysis due to their
optimum characteristics.
4.5.1. Antibacterial Activities
Antibacterial activities of scaffolds were performed via agar disc-diffusion assay against various
sever pathogens (E. coli, S. aureus and P. aeruginosa) and zone of inhibition was measured as seen in
Figure 7 [35]. Antibacterial activity of scaffolds is due to the penetration of silica and hydroxyapatite
nano-particles into bacteria to interact with the cellular protein. The denatured proteins were
caused by silica and hydroxyapatite nanoparticles and by the accretion of external fluids to give
silica/hydroxyapatite scaffolds better antibacterial activities. The charged bacterial surface membrane
(phospholipids and lipopolysaccharides) interacts with several functional groups of bioactive polymeric
scaffolds [36,37]. These active sites of bioactive polymeric scaffolds allowed their changes into the
bacterial membrane to obstruct bacterial activity. Bacterial growth is overdue due to the interaction
between the polymeric portion of scaffold and bacterial DNA. Molecular alteration in DNA because of
polymeric and SiO2/HAp nanoparticles of bioactive polymeric scaffolds that caused little to no bacterial
growth. All samples of polymeric bioactive scaffolds, therefore, exhibited antibacterial activity due to
components of polymeric bioactive scaffolds and also increasing quantities of silica nanoparticles [38].
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4.5.2. Cytotoxicity
All scaffolds were incubated into culture medium at 37 ◦C for 24, 48 and 72 h. Culture media
contained 90% DMEM glucose followed by 2 mmol L−1 glutamine, 10% FBS and 1% penicillin. Attached
cells demonstrate ideal MC3T3-E1 cell line morphology for all samples of polymeric bioactive scaffolds,
where cells are cylindrical with proper cell bodies. Cells attached to the well-bottom are comparatively
less retained morphology as compared to control [33,39]. Figure 8, on the contrary, detects a particular
pattern. PBS3 is found to have become more supportive of cells as it has added a large number of cells
to the bottom of the well plate without any deformation of cell morphology compared to +ve-control.
Whereas PBS1 has the least growth in cells compared to PBS3 because of an increasing amount of the
n-SiO2. The increasing amount of silica makes scaffolds more biocompatible and increases the growth
of MC3T3-E1 over time. In comparison, the negative control depicted smaller or no cells growth. It is
therefore evident from the results that grafted XG-based biomaterials strengthened osteoblast cell
attachment by increasing the n-SiO2 content.Polymers 2019, 11, x FOR PEER REVIEW 13 of 17 
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4.5.3. Neutral Red Assay
Cytotoxicity assay was carried out using the pre-osteoblast mouse (MC3T3-E1) cells by rising
against all scaffolds. Cell viability was evaluated for each concentration of all samples and recorded at
different time intervals using Neutral red uptake assay by incubation (24, 48 and 72 h) [31,33]. As the
amount of n-SiO2 increases, polymeric bioactive scaffolds show greater cell viability and non-toxicity
against pre-osteoblast mouse (MC3T3-E1) cells (Figure 9). PBS3 has no or less toxic cell viability
that promotes pre-osteoblast (MC3T3-E1) cell differentiation to help the bone formation and plays an
important role in tissue engineering for bone regeneration.
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Figure 9. The cell viability of all polymeric bioactive scaffold samples was investigated using their
extracts (0.125 to 2.00 mg mL−1). These five different concentrations have incubated using pre-osteoblast
(MC3T3-E1) cells at different time intervals (24, 48 and 72 h) at 37 ◦C.
4.5.4. SEM Analysis of Cell Culture
The PBS3 sample was selec ed for SEM analysis because of optimal swelling, mechanical, porosity,
pore size, antibacterial and biocompatibility. Adherence of MC3T3-E1 pre-osteoblast cells to PBS3 was
analyzed using SEM (Figure 8) and presented via micrographs (A) PBS3, (B) Positive control (C) after
48 h, 72 h and 7 days of cultivation, respectively [31,33]. After specific incubation time (48 h, 72 h and
7 days), the pre-osteoblast MC3T3-E1 cells responded to PBS3 by exhibiting bioactive and unique cell
attachment, which spread all over the surface (Figure 10). Hence, the PBS3 was found to good in cell
adherence and proliferation [33,39].
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Figure 10. Scanning electron microscopy (SEM) micrographs of cell growth over PBS3 at (a) 48 h,
(b) 72 h and (c) 7 days, at 100 µm and upper right at 200 µm respectively and the red circle shows the
cell growth area.
5. Conclusions
Polysaccharides are prominent polymeric biomaterials for many biomedical applications. We have
used XG to fabricate polymeric bioactive scaffolds for bone tissue engineering applications. The different
amounts of n-SiO2 have different porosity, pore size, swelling and biomechanical behavior of these
polymeric bioactive scaffolds for support and growth bones. The ultimate compression strength of
PBS3 is ~5.7 MPa, which is closer to cancellous bone strength. PBS3 polymeric bioactive scaffold
exhibited adequate porosity (86.5% ± 1%) with a pore size (105 ± 2 µm) that is essential for osteogenesis.
PBS3 was found to be antibacteri l ag inst several infections causing pathogens. PBS3 is a more
biologically active scaffold th t encouraged osteoblast cell lin growth ith adequate cell viability
and cell growth. The overall utcome has verified that polymeric bioactive scaffolds are potential
biomaterial for bone tissue engineering.
6. Li it ti s
The increasing a ount of ceramic contents (n-SiO2) changes behavior from polymeric to
amorphous that also changed the physicochemical properties of the scaffolds. Further increasing
amount of n-SiO2 causes a bigger pore size that fails mechanical properties that may not support these
scaffolds mechanically. Since we are investigating other possible material to increase more mechanical
properties by enhancing physicochemical and biological properties.
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